Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 198,737 shares at $0.01 ($2K) on 2025-07-08, disclosed to the SEC on 2025-07-10.
Open-market purchase of $2k OTLC by CHAIRMAN AND CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.01 | 94,736 | $947 | 47.7% |
| 2 | $0.01 | 1 | $0 | 0.0% |
| 3 | $0.01 | 104,000 | $1K | 52.3% |
| Total | $0.01 avg | 198,737 | $2K | 100% |
| Filing → |
| OTLC | BUY | 2026-06-17 | $15K | — | Filing → |
| OTLC | BUY | 2025-01-31 | $10K | — | Filing → |
| OTLC | BUY | 2024-11-26 | $9K | — | Filing → |